Bio Protocol builds onchain science model as White House pushes to reform $200B in research funding
The shift towards decentralized science models like Bio Protocol could democratize research funding, accelerating innovation and reducing bureaucracy. The post Bio Protocol builds onchain science model as White House pus...
Archive context
Published in the last two hours.
The shift towards decentralized science models like Bio Protocol could democratize research funding, accelerating innovation and reducing bureaucracy.
The post Bio Protocol builds onchain science model as White House pushes to reform $200B in research funding appeared first on Crypto Briefing.
Why this matters
This research story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Crypto BriefingRelated market context
Odds of CLARITY crypto legislation passing sink to 27% as Treasury, White House, SEC, and Senate leads quit
Tyler Williams served as Secretary Scott Bessent's principal adviser on blockchain and digital asset policy, making him one of Tre...
POAP Winds Down After Five Years and Nearly 7.6 Million Onchain Badges
POAP, the Proof of Attendance Protocol, is shutting down after more than five years, co-founder Isabel Gonzalez said Monday. The p...
Cloudflare Opens Stablecoin Wallet Handles as It Builds the Buy Side of Agent Payments
Cloudflare began rolling out stablecoin wallets for AI agents on Tuesday, opening the identity layer of a product that will eventu...
Blockchains’ onchain revenue share drops to 25% as apps dominate
The shift towards app dominance in onchain revenue highlights the growing importance of application layers over traditional blockc...
Tokenized stocks surpass $3B in onchain market cap
The rapid growth of tokenized stocks highlights a shift towards blockchain-based financial products, raising questions about marke...
Bitcoin spot ETFs pull in $381M this week as buying pressure builds near $64K
The recent surge in Bitcoin spot ETF inflows highlights shifting investor sentiment, but regulatory and macroeconomic factors coul...